SALIX PHARMACEUTICALS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for SALIX PHARMACEUTICALS INC NOTE 5.500% 8/1, CUSIP 795435AB2.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for SALIX PHARMACEUTICALS INC NOTE 5.500% 8/1, CUSIP 795435AB2.